Chemist.net Cookie Policy : We use cookies to enhance your user experience. To find out more please view our cookie policy
Alonate-P 400 mg/g Oral Paste (Pyrantel Horse Wormer) - POM-VPS
SKU :
VETALO004
EAN :
5055564400846
Alonate-P 400 mg/g Oral Paste for Horses and Ponies contains the active ingredient pyrantel embonate and is used to treat and control adult infections of large and small strongyles, pinworms and roundworms. It can also be double-dosed to treat and control tapeworm.
Out of Stock
SKU
VETALO004
£9.30
This medicine can only be sold under the supervision of a Pharmacist, therefore you will need to answer a few short questions so our Pharmacist can ensure this product is suitable for you.
Browse our full range of:
Description
Alonate-P 400 mg/g Oral Paste for Horses and Ponies
Legal Category: POM-VPS
Alonate-P 400 mg/g Oral Paste for Horses and Ponies contains the active ingredient pyrantel embonate and is used to treat and control adult infections of large and small strongyles, pinworms and roundworms. It can also be double-dosed to treat and control tapeworm.
Effective Against
- Large strongyles: Stronglylus vulgaris, S. edentatus, S. equinus.
- Small strongyles: Trichonema spp. (Cyathostomes), Triodontophorus spp.
- Pinworms: Oxyuris equi, Probstmayria vivipara.
- Large roundworms: Parascaris equorum.
- Tape worms: Anoplocephala perfoliata.
Alonate-P 400 mg/g Oral Paste for Horses and Ponies is safe for horses and ponies of all ages, including sucklings, studs and pregnant and lactating mares, provided the recommendations are followed.
Each syringe contains 28.5g of paste and treats 600kg bodyweight at the standard dose, or 300kg when double-dosing for tapeworm. Each graduation of the syringe is sufficient for the treatment of 100kg bodyweight.
Directions
To ensure administration of a correct dose, body weight should be determined as accurately as possible; accuracy of the dosing device should be checked.
Deposit the product on tongue of the animal and allow the animal to swallow.
Control and treatment of Strongyles, Oxyuris and Parascaris
Use at a dose rate of 19 mg pyrantel embonate per kg bodyweight.
- Foals (1-8 months of age): dose every 4 weeks.
- Horses (over 8 months of age): dose every 6-8 weeks, but during the summer and autumn when at grass dose every 4-6 weeks. Always dose 3-4 days before turning out after in wintering.
- Suckler mares: It has been shown that reduction of strongyle challenge to the suckling foal at pasture can be achieved by using clean pasture (reseeded or not grazed the previous year by horses), dosing the mare 3-4 days before turning out and then at intervals of 2-4 weeks until the end of Autumn. Ideally mares with foals should go out to 'clean' pasture or, if this is not possible, delay turning them out until June.
Control and treatment of Anoplocephala (Tapeworm)
- Use at a dose rate of 38mg pyrantel embonate per kg bodyweight (i.e. twice the dose used for stronglyes).
- The need for retreatment may vary, but if considered necessary, should be carried out after an interval of 6 weeks.
Ingredients
- Active Ingredient: Pyrantel embonate 400mg/g
- Other Ingredients: Butylated Hydroxytoluene, Polysorbate 80, Silica Colloidal Anydrous, Maize Oil.
Cautions
- Do not use in foals less than 4 weeks of age.
- Do not use in severely debilitated animals.
- Do not use in cases of hypersensitivity to the active substance or to any of the excipients.
- The same syringe should only be used to dose two animals if they are both healthy and are either running together, or are on the same premises and in direct contact with each other.
- Combined administration of pyrantel and levamisole or piperazine is not recommended.
Special precautions to be taken by the person administering the veterinary medicinal product to animals:
- Direct contact with the skin should be avoided.
- Wash hands and any other parts of the body which comes into contact with the product after use.
- Avoid handling the product if you know you are hypersensitive to pyrantel.
Care should be taken to avoid the following practices because they increase the risk of development of resistance and could ultimately result in ineffective therapy:
- Too frequent and repeated use of anthelmintics from the same class, over an extended period of time.
- Underdosing, which may be due to underestimation of weight, misadministration of the product, or lack of calibration of the dosing device (if any).
Withdrawal Periods
- Not to be used in horses and ponies intended for human consumption.
- Treated horses may never be slaughtered for human consumption. The horse must have been declared as not intended for human consumption under national horse passport legislation.